Deutsche Bank Aktiengesellschaft Has Lowered Expectations for Sarepta Therapeutics (NASDAQ:SRPT) Stock Price
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target reduced by stock analysts at Deutsche Bank Aktiengesellschaft from $124.00 to $99.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “hold” rating on the biotechnology company’s stock. Deutsche Bank Aktiengesellschaft’s price objective indicates a potential upside of […]
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target reduced by stock analysts at Deutsche Bank Aktiengesellschaft from $124.00 to $99.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “hold” rating on the biotechnology company’s stock. Deutsche Bank Aktiengesellschaft’s price objective indicates a potential upside of […]
